Management of the Transplant Recipient with Chronic Hepatitis C

被引：22

作者：

Burton, James R., Jr. ^{[1
]}

Everson, Gregory T. ^{[1
]}

机构：

[1] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA

来源：

CLINICS IN LIVER DISEASE | 2013年 / 17卷 / 01期

关键词：

Telaprevir; Boceprevir; Transplant; Hepatitis C virus; INTERFERON-FREE REGIMEN; LIVER-TRANSPLANTATION; ANTIVIRAL THERAPY; PLUS RIBAVIRIN; DECOMPENSATED CIRRHOSIS; PEGINTERFERON ALPHA-2B; PEGYLATED INTERFERON; COMBINATION THERAPY; PROTEASE INHIBITOR; DRUG-INTERACTIONS;

D O I：

10.1016/j.cld.2012.09.013

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

More than one-third of listed potential liver recipients in the US are infected with the hepatitis C virus (HCV). Recurrence of infection with HCV after liver transplantation is associated with accelerated graft loss and diminished patient survival. Current HCV treatments using peginterferon and ribavirin either alone or with first generation protease inhibitors (telaprevir, boceprevir) are limited by suboptimal viral response, drug-drug interaction, and side effects, some of which may be graft- or life-threatening. Rapid advances in new drug therapy for HCV promise to improve outcomes, reduce side effects and drug-drug interaction, shorten treatment duration, and simplify treatment regimens.

引用

页码：73 / +

页数：20

共 53 条

[1]

Amarapurkar Deepak N, 2005, Trop Gastroenterol, V26, P119

[2] Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation [J].

Annicchiarico, B. E. ;

Siciliano, M. ;

Avolio, A. W. ;

Caracciolo, G. ;

Gasbarrini, A. ;

Agnes, S. ;

Castagneto, M. .

TRANSPLANTATION PROCEEDINGS, 2008, 40 (06) :1918-1920

[3] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].

Bacon, Bruce R. ;

Gordon, Stuart C. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Vierling, John M. ;

Zeuzem, Stefan ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Boparai, Navdeep ;

Burroughs, Margaret ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Esteban, Rafael .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217

[4] Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin [J].

Berenguer, Marina .

JOURNAL OF HEPATOLOGY, 2008, 49 (02) :274-287

[5]

Burton JR, 2012, AM J TRANSPLANT, pLB1

[6] Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study [J].

Carrion, Jose A. ;

Martinez-Bauer, Eva ;

Crespo, Gonzalo ;

Ramirez, Santseharay ;

Perez-del-Pulgar, Sofia ;

Carlos Garcia-Valdecasas, Juan ;

Navasa, Miquel ;

Forns, Xavier .

JOURNAL OF HEPATOLOGY, 2009, 50 (04) :719-728

[7] Cyclosporine A-Based Immunosuppression Reduces Relapse Rate After Antiviral Therapy in Transplanted Patients With Hepatitis C Virus Infection: A Large Multicenter Cohort Study [J].

Castells, Ll. ;

Campos, I. ;

Bilbao, I. ;

Navasa, M. ;

Carrion, J. ;

Forns, X. ;

Berenguer, M. ;

Aguilera, V. ;

Prieto, M. ;

Fernandez, I. ;

Meneu, J. C. ;

Ulloa, E. ;

Fernandez, J. R. ;

Suarez, M. J. ;

Pascasio, J. M. ;

Sousa, J. M. ;

Casanovas, T. ;

Baliella, C. ;

Barcena, R. ;

Rodriguez, M. ;

de la Mata, M. ;

Barrera, P. ;

Salcedo, M. ;

Banares, R. ;

Otero, A. ;

Suarez, F. ;

Banos, I. ;

Tome, S. ;

Herrero, I. ;

Guilera, M. .

TRANSPLANTATION, 2011, 92 (03) :334-340

[8] Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders [J].

Chayama, Kazuaki ;

Takahashi, Shoichi ;

Toyota, Joji ;

Karino, Yoshiyasu ;

Ikeda, Kenji ;

Ishikawa, Hiroki ;

Watanabe, Hideaki ;

McPhee, Fiona ;

Hughes, Eric ;

Kumada, Hiromitsu .

HEPATOLOGY, 2012, 55 (03) :742-748

[9] Host genomics and HCV treatment response [J].

Clark, Paul J. ;

Thompson, Alexander J. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) :212-222

[10]

Coilly A, 2012, LIVER TRANSPLANT, V18, pS84

← 1 2 3 4 5 6 →